BOC Sciences provides a wide range of research chemicals and biochemicals including inhibitors, building blocks, GMP Products, impurities and metabolites, APIs for Veterinary, Natural Compounds, ADCs, Stem Cell Molecule and chiral compounds.
| Product | Description | |
|---|---|---|
| Maximin-H15 | The source of Maximin-H15 is Bombina maxima. Maximin-H15 shows antimicrobial activity against bacteria and against the fungus C.albicans. It also shows strong hemolytic activity. |  |
| Maximin-H16 | The source of Maximin-H16 is Bombina maxima. Maximin-H16 shows antimicrobial activity against bacteria and against the fungus C.albicans. It also shows strong hemolytic activity. | |
| Maximin H2 | Maximin H2 has antibacterial and antifungal activities. The source of Maximin H2 is Bombina maxima [Giant fire-bellied toad]. It is highly homologous with bombinin H peptides. Grades: >97% by HPLC. Molecular formula: C91H164N22O23S. Mole weight: 1966.47. | |
| Maximin H3 | Maximin H3 shows antibacterial activity against both Gram-positive and Gram-negative bacteria. It also shows antimicrobial activity against the fungus C.albicans. Maximin H3 has strong hemolytic activity. | |
| Maximin H39 | Maximin H39 has antibacterial and antifungal activities. The source of Maximin H39 is Bombina maxima [Giant fire-bellied toad]. | |
| Maximin H4 | Maximin H4 has antibacterial and antifungal activities. The source of Maximin H4 is Bombina maxima [Giant fire-bellied toad]. It is highly homologous with bombinin H peptides. Grades: >98% by HPLC. Molecular formula: C92H166N24O22. Mole weight: 1960.44. | |
| Maximin-H5 | Maximin H5 is a C-terminally amidated, anionic host defence peptide (MH5N) from toads of the Bombina genus, which was shown to possess activity against the glioma cell line, T98G (EC50 = 125 μM). | |
| Maximin-H6 | The source of Maximin-H6 is Bombina maxima. Maximin-H6 shows antimicrobial activity against bacteria and against the fungus C.albicans. It also shows strong hemolytic activity. | |
| Maximin-H7 | The source of Maximin-H7 is Bombina maxima. Maximin-H7 shows antimicrobial activity against bacteria and against the fungus C.albicans. It also shows strong hemolytic activity. | |
| Maximin-H8 | The source of Maximin-H8 is Bombina maxima. Maximin-H8 shows antimicrobial activity against bacteria and against the fungus C.albicans. It also shows strong hemolytic activity. | |
| Maximin-H9 | The source of Maximin-H9 is Bombina maxima. Maximin-H9 shows antimicrobial activity against bacteria and against the fungus C.albicans. It also shows strong hemolytic activity. | |
| Maximin-Ht | Maximin-Ht is isolated from Bombina maxima and has antimicrobial activity. Grades: >85% (SDS-PAGE). | |
| Maximin-Hu | Maximin-Hu is isolated from Bombina maxima and has antimicrobial activity. Grades: >85% (SDS-PAGE). | |
| Maximin-Hv | The source of Maximin-Hv is Bombina maxima. Maximin-Hv shows antimicrobial activity against bacteria and against the fungus C.albicans. It also shows strong hemolytic activity. | |
| Maximin-Hw | The source of Maximin-Hw is Bombina maxima. Maximin-Hw shows antimicrobial activity against bacteria and against the fungus C.albicans. It also shows strong hemolytic activity. | |
| Maximin S2 | Maximin S2 has an activity against mycoplasma but has no activity against common Gram-positive and Gram-negative bacteria nor fungi. It has no hemolytic activity. | |
| Maximin S3 | Maximin S3 has an activity against mycoplasma but has no activity against common Gram-positive and Gram-negative bacteria nor fungi. It has no hemolytic activity. Grades: >95% by HPLC. Molecular formula: C84H131N23O27S2. Mole weight: 1959.20. | |
| Maximin S4 | Maximin S4 showed no activity against commonly met Gram-positive or negative bacteria but is active against mycoplasma, a cell wall-free bacteria. Grades: >95% by HPLC. Molecular formula: C91H148N26O26S2. Mole weight: 2086.43. | |
| Maximin S5 | Maximin S5 has antibacterial activity. The source of Maximin S5 is Bombina maxima [Giant fire-bellied toad]. Grades: >97% by HPLC. Molecular formula: C87H139N23O26S2. Mole weight: 1987.30. | |
| Maximin-y | Maximin-y shows antimicrobial activity against bacteria and against the fungus C.albicans. It has little hemolytic activity. | |
| Maximin y type 2 precursor | Maximin y type 2 precursor has antibacterial and antifungal activity. The source of Maximin y type 2 precursor is Bombina maxima [Giant fire-bellied toad]. Grades: >95% by HPLC. | |
| Maximin-z | Maximin-z has antibacterial and antifungal activities. Maximin-z was found in Bombina maxima. | |
| MBD-7 | MBD-7 is isolated from Mus musculus (Mouse) and has bactericidal activity. Alternative Names: Beta-defensin 7; BD-7; Defensin, beta 7. | |
| MBHA Resin | MBHA Resin. | |
| MBMAP28 | BMAP-28 has broad antimicrobial activities and confers protection in an animal model: mouse of bacterial infection or sepsis. | |
| M(Boc) Acetic acid | A nucleobase for PNA synthesis. Alternative Names: (6-tert-butoxycarbonylaminopyridin-3-yl) acetic acid. Grades: 98%. CAS No. 1256337-02-6. Molecular formula: C12H16N2O4. Mole weight: 252.27. | |
| MBP (85-106) guinea pig, MBP (86-107) human | MBP (85-106) guinea pig, MBP (86-107) human is a 85-106 fragment of the guinea pig, myelin basic protein (MBP) or 86-107 fragment of the human MBP. It is used in multiple sclerosis research. Alternative Names: H-Val-Val-His-Phe-Phe-Lys-Asn-Ile-Val-Thr-Pro-Arg-Thr-Pro-Pro-Pro-Ser-Gln-Gly-Lys-Gly-Arg-OH; Val-Val-His-Phe-Phe-Lys-Asn-Ile-Val-Thr-Pro-Arg-Thr-Pro-Pro-Pro-Ser-Gln-Gly-Lys-Gly-Arg. Molecular formula: C113H180N34O28. Mole weight: 2463. | |
| Mca-Ala-Pro-Lys(Dnp)-OH | Mca-Ala-Pro-Lys(Dnp)-OH, a FRET substrate for angiotensin-converting enzyme 2 (ACE2), is used to monitor enzyme activity in plasma, urine, heart and lungs. Alternative Names: Mca-APK(Dnp); L-Lysine, N-[2-(7-methoxy-2-oxo-2H-1-benzopyran-4-yl)acetyl]-L-alanyl-L-prolyl-N6-(2,4-dinitrophenyl)-; N-[(7-Methoxy-2-oxo-2H-chromen-4-yl)acetyl]-L-alanyl-L-prolyl-N6-(2,4-dinitrophenyl)-L-lysine; (S)-6-((2,4-dinitrophenyl)amino)-2-((S)-1-((S)-2-(2-(7-methoxy-2-oxo-2H-chromen-4-yl)acetamido)propanoyl)pyrrolidine-2-carboxamido)hexanoic acid. Grades: ≥95%. CAS No. 305336-82-7. Molecular formula: C32H36N6O12. Mole weight: 696.67. | |
| Mca-Amyloid β/A4 Protein Precursor770 (667-676)-Lys(Dnp)-Arg-Arg amide | Mca-Amyloid β/A4 Protein Precursor770 (667-676)-Lys(Dnp)-Arg-Arg amide, a fluorescent (FRET) peptide substrate containing the wild-type amyloid precursor protein (APP) β-secretase cleavage site, is used to determine the β-secretase-like activity of thimet oligopeptidase (TOP, EC 3.4.24.15). TOP is a potential β-secretase candidate and is involved in APP processing in vivo. Alternative Names: Mca-APP770 (667-676)-Lys(Dnp)-Arg-Arg amide; Mca-Ser-Glu-Val-Lys-Met-Asp-Ala-Glu-Phe-Arg-Lys(Dnp)-Arg-Arg-NH2; Mca-SEVKMDAEFRK(Dnp)RR-amide. Grades: ≥95% by HPLC. CAS No. 1802078-33-6. Molecular formula: C87H129N27O28S. Mole weight: 2033.21. | |
| Mca-Arg-Pro-Lys-Pro-Tyr-Ala-Nva-Trp-Met-Lys(Dnp)-NH2 | Mca-Arg-Pro-Lys-Pro-Tyr-Ala-Nva-Trp-Met-Lys(Dnp)-NH2, the FRET substrate, is hydrolyzed 60 times more rapidly by stromelysin 1 (MMP-3) (kcat/Km= 59400 M-1s-1) than by interstitial collagenase (MMP-1). However, it shows little discrimination between MMP-3, gelatinase A (MMP-2) (kcat/Km= 54000 M-1s-1), and gelatinase B (MMP-9) (kcat/Km = 55300 M-1s-1). This fluorogenic substrate is digested by Metalloelastase (MMP-12) with a kcat/Km of 243000 M-1s-1. Alternative Names: NFF-2; 7-Methoxycoumarin-4-acetyl-Arg-Pro-Lys-Pro-Tyr-Ala-Nva-Trp-Met-(2,4-dinitrophenyl)Lys amide; N2-[(7-Methoxy-2-oxo-2H-chromen-4-yl)acetyl]-L-arginyl-L-prolyl-L-lysyl-L-prolyl-L-tyrosyl-L-alanyl-L-norvalyl-L-tryptophyl-L-methionyl-N6-(2,4-dinitrophenyl)-L-lysinamide. Grades: ≥95%. CAS No. 158584-08-8. Molecular formula: C79H105N19O19S. Mole weight: 1656.86. | |
| Mca-(Asn670,Leu671)-Amyloid β/A4 Protein Precursor770 (667-675)-Lys(Dnp) | Mca-(Asn670,Leu671)-Amyloid β/A4 Protein Precursor770 (667-675)-Lys(Dnp) is a pro-memapsin-2 fluorogenic substrate (FRET) containing the β-secretase site of the Swedish mutation of APP, SEVNLDAEF. Alternative Names: Mca-(Asn670,Leu671)-APP770 (667-675)-Lys(Dnp); Mca-Ser-Glu-Val-Asn-Leu-Asp-Ala-Glu-Phe-Lys(Dnp)-OH; N-[(7-Methoxy-2-oxo-2H-chromen-4-yl)acetyl]-L-seryl-L-α-glutamyl-L-valyl-L-asparaginyl-L-leucyl-L-α-aspartyl-L-alanyl-L-α-glutamyl-L-phenylalanyl-N6-(2,4-dinitrophenyl)-L-lysine; L-Lysine, N-[2-(7-methoxy-2-oxo-2H-1-benzopyran-4-yl)acetyl]-L-seryl-L-α-glutamyl-L-valyl-L-asparaginyl-L-leucyl-L-α-aspartyl-L-alanyl-L-α-glutamyl-L-phenylalanyl-N6-(2,4-dinitrophenyl)-. Grades: ≥95%. CAS No. 1802078-31-4. Molecular formula: C68H88N14O27. Mole weight: 1533.53. | |
| Mca-(Asn670,Leu671)-Amyloid β/A4 Protein Precursor770 (667-675)-Lys(Dnp) amide | Mca-(Asn670,Leu671)-Amyloid β/A4 Protein Precursor770 (667-675)-Lys(Dnp) amide is a fluorogenic (FRET) substrate for pro-memapsin-2 containing the β-secretase site of the Swedish mutation of APP. Its kinetic parameters at pH 4.5 are Km = 4.5 μM and kcat = 0.25 min-1. Alternative Names: Mca-(Asn670,Leu671)-APP770 (667-675)-Lys(Dnp) amide; Mca-Ser-Glu-Val-Asn-Leu-Asp-Ala-Glu-Phe-Lys(Dnp)-NH2; N-[(7-Methoxy-2-oxo-2H-chromen-4-yl)acetyl]-L-seryl-L-α-glutamyl-L-valyl-L-asparaginyl-L-leucyl-L-α-aspartyl-L-alanyl-L-α-glutamyl-L-phenylalanyl-N6-(2,4-dinitrophenyl)-L-lysinamide; L-Lysinamide, N-[2-(7-methoxy-2-oxo-2H-1-benzopyran-4-yl)acetyl]-L-seryl-L-α-glutamyl-L-valyl-L-asparaginyl-L-leucyl-L-α-aspartyl-L-alanyl-L-α-glutamyl-L-phenylalanyl-N6-(2,4-dinitrophenyl)-; Mca-SEVNLDAEFK(Dnp) amide. Grades: ≥95%. CAS No. 1802078-32-5. Molecular formula: C68H89N15O26. Mole weight: 1532.54. | |
| Mca-(endo-1a-Dap(Dnp))-TNF-α (-5 to +6) amide (human) | Mca-(endo-1a-Dap(Dnp))-TNF-α (-5 to +6) amide (human), a fluorogenic (FRET) peptide substrate, is used for the tumor necrosis factor (TNF) converting enzyme (TACE, ADAM-17 endopeptidase). Alternative Names: Mca-(endo-1a-Dap(Dnp))-TNF-a (-5 to +6) amide (human); Mca-Pro-Leu-Ala-Gln-Ala-Val-Dap(Dnp)-Arg-Ser-Ser-Ser-Arg-NH2; L-Argininamide, 1-[(7-methoxy-2-oxo-2H-1-benzopyran-4-yl)acetyl]-L-prolyl-L-leucyl-L-alanyl-L-glutaminyl-L-alanyl-L-valyl-3-[(2,4-dinitrophenyl)amino]-L-alanyl-L-arginyl-L-seryl-L-seryl-L-seryl-; 1-[(7-Methoxy-2-oxo-2H-chromen-4-yl)acetyl]-L-prolyl-L-leucyl-L-alanyl-L-glutaminyl-L-alanyl-L-valyl-3-[(2,4-dinitrophenyl)amino]-L-alanyl-L-arginyl-L-seryl-L-seryl-L-seryl-L-argininamide. Grades: ≥95% by HPLC. CAS No. 192723-42-5. Molecular formula: C69H103N23O24. Mole weight: 1638.72. | |
| Mca-Gly-Lys-Pro-Ile-Leu-Phe-Phe-Arg-Leu-Lys(Dnp)-D-Arg-NH2 | Mca-Gly-Lys-Pro-Ile-Leu-Phe-Phe-Arg-Leu-Lys(Dnp)-D-Arg-NH2, a FRET substrate for cathepsin D and E, is also cleaved by napsin A. Alternative Names: MOCAc-GKPILFFRL-{Lys(Dnp)}-{D-Arg}-NH2; Mca-GKPILFFRL-Dpa-r-amide; MOCAc-Gly-Lys-Pro-Ile-Leu-Phe-Phe-Arg-Leu-{Lys(Dnp)}-{D-Arg}-NH2; N-[(7-Methoxy-2-oxo-2H-chromen-4-yl)acetyl]glycyl-L-lysyl-L-prolyl-L-isoleucyl-L-leucyl-L-phenylalanyl-L-phenylalanyl-L-arginyl-L-leucyl-N6-(2,4-dinitrophenyl)-L-lysyl-D-argininamide; D-Argininamide, N-[2-(7-methoxy-2-oxo-2H-1-benzopyran-4-yl)acetyl]glycyl-L-lysyl-L-prolyl-L-isoleucyl-L-leucyl-L-phenylalanyl-L-phenylalanyl-L-arginyl-L-leucyl-N6-(2,4-dinitrophenyl)-L-lysyl-; Cathepsin D and E FRET Substrate. Grades: ≥90%. CAS No. 839730-93-7. Molecular formula: C85H122N22O19. Mole weight: 1756.01. | |
| MCA-Lys-Leu-Lys(Dnp) | MCA-Lys-Leu-Lys(Dnp). Alternative Names: N6-(2,4-dinitrophenyl)-N2-(2-(7-methoxy-2-oxo-2H-chromen-4-yl)acetyl)-L-lysyl-L-leucyl-L-lysine. Molecular formula: C36H47N7O12. Mole weight: 769.81. | |
| Mca-PL | Mca-PL is a fluorogenic peptide that can be used in the synthesis of Mca-PLGL-Dpa-AR-NH2, a fluorogenic substrate for matrix metalloproteinase-2 (MMP-2) and MMP-7. Alternative Names: Matrix Metalloproteinase-2 / Matrix Metalloproteinase-7 Fluorogenic Substrate Control; Mca-Pro-Leu-OH; MMP-2/MMP-7 Fluorogenic Substrate Control; N-[1-[(7-methoxy-2-oxo-2H-1-benzopyran-4-yl)acetyl]-L-prolyl]-L-leucine. Grades: ≥95%. CAS No. 140430-55-3. Molecular formula: C23H28N2O7. Mole weight: 444.48. | |
| Mca-Pro-Leu-Gly-Leu-Glu-Glu-Ala-Dap(Dnp)-NH2 | Mca-Pro-Leu-Gly-Leu-Glu-Glu-Ala-Dap(Dnp)-NH2 is a highly selective MMP-12 FRET substrate with a kcat/Km value of 1.85·105 M-1s-1. It is a poor substrate of other MMPs with the exception of MMP-13 (kcat/Km = 0.53·105 M-1s-1) and MMP-9 (kcat/Km = 0.33·105 M-1s-1). Alternative Names: L-Alaninamide, 1-[(7-methoxy-2-oxo-2H-1-benzopyran-4-yl)acetyl]-L-prolyl-L-leucylglycyl-L-leucyl-L-α-glutamyl-L-α-glutamyl-L-alanyl-3-[(2,4-dinitrophenyl)amino]-; 1-[(7-Methoxy-2-oxo-2H-1-benzopyran-4-yl)acetyl]-L-prolyl-L-leucylglycyl-L-leucyl-L-alpha-glutamyl-L-alpha-glutamyl-L-alanyl-3-[(2,4-dinitrophenyl)amino]-L-alaninamide. Grades: 95%. CAS No. 891198-38-2. Molecular formula: C53H70N12O20. Mole weight: 1195.19. | |
| MCA-SEVNLDAEFR-K(Dnp)-RR, amide | It is a FRET-based substrate. Alternative Names: Mca-(Asn670, Leu671)-APP770(667-676)-Lys(Dnp)-Arg-Arg amide; MCA-Ser-Glu-Val-Asn-Leu-Asp-Ala-Glu-Phe-Arg-Lys(Dnp)-Arg-Arg-NH2; Mca-(Asn670, Leu671)-Amyloid beta/A4 Protein Precursor770(667-676)-Lys(Dnp)-Arg-Arg amide. Grades: ≥95%. CAS No. 438625-61-7. Molecular formula: C86H125N27O29. Mole weight: 2001.08. | |
| Mca-YVADAP-Lys(Dnp)-OH | Mca-YVADAP-Lys(Dnp)-OH is a fluorogenic substrate for caspase-1 and angiotensin-converting enzyme 2 (ACE2). It is cleaved by caspase-1 or ACE2 to release the fluorescent moiety 7-methoxycoumarin-4-acetyl (Mca), which can be used to quantify enzyme activity. Alternative Names: Mca-Tyr-Val-Ala-Asp-Ala-Pro-Lys(Dnp)-OH; Caspase-1 Fluorogenic Substrate V; N-[2-(7-methoxy-2-oxo-2H-1-benzopyran-4-yl)acetyl]-L-tyrosyl-L-valyl-L-alanyl-L-α-aspartyl-L-alanyl-L-prolyl-N6-(2,4-dinitrophenyl)-L-lysine; L-Lysine, N-[2-(7-methoxy-2-oxo-2H-1-benzopyran-4-yl)acetyl]-L-tyrosyl-L-valyl-L-alanyl-L-alpha-aspartyl-L-alanyl-L-prolyl-N6-(2,4-dinitrophenyl)-. Grades: ≥95%. CAS No. 189696-01-3. Molecular formula: C53H64N10O19. Mole weight: 1145.15. | |
| MCdef | MCdef is a defensin-like peptide detected in hemocytes of Manila clams (Ruditapes philippinarum). MCdef showed highest activity against Streptococcus iniae and Staphylococcus aureus. | |
| MCD Peptide | 22-amino acid peptide with a strongly basic character and 2 disulfide bridges, , from Apis mellifera bee venom, a blocker of voltage-sensitive K+ channels with potent convulsant activity. Alternative Names: Peptide 401; Mast Cell Degranulating (MCD) Peptide; Ile-Lys-Cys-Asn-Cys-Lys-Arg-His-Val-Ile-Lys-Pro-His-Ile-Cys-Arg-Lys-Ile-Cys-Gly-Lys-Asn-NH2 (Disulfide bridge: Cys3-Cys15, Cys5-Cys19); L-isoleucyl-L-lysyl-L-cysteinyl-L-asparagyl-L-cysteinyl-L-lysyl-L-arginyl-L-histidyl-L-valyl-L-isoleucyl-L-lysyl-L-prolyl-L-histidyl-L-isoleucyl-L-cysteinyl-L-arginyl-L-lysyl-L-isoleucyl-L-cysteinyl-glycyl-L-lysyl-L-asparaginamide (3->15),(5->19)-bis(disulfide). Grades: ≥95%. CAS No. 32908-73-9. Molecular formula: C110H192N40O24S4. Mole weight: 2587.22. | |
| MC-Gly-Gly-Phe-Gly | MC-Gly-Gly-Phe-Gly is a cleavable ADC linker used for antibody-drug conjugates (ADCs). Alternative Names: (S)-5-Benzyl-18-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-4,7,10,13-tetraoxo-3,6,9,12-tetraazaoctadecan-1-oic acid. Grades: >98.0%. CAS No. 2413428-36-9. Molecular formula: C25H31N5O8. Mole weight: 529.54. | |
| MC-Gly-Gly-Phe-Gly-NH-CH2-O-CH2COOH | MC-Gly-Gly-Phe-Gly-NH-CH2-O-CH2COOH is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Alternative Names: Glycinamide,N-[6-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-1-oxohexyl]glycylglycyl-L-phenylalanyl-N-[(carboxymethoxy) methyl]-. Grades: >98.0%. CAS No. 1599440-25-1. Molecular formula: C28H36N6O10. Mole weight: 616.62. | |
| MCH (human, mouse, rat) | MCH is an endogenous melanin-concentration hormone receptor agonist with IC50 values of 0.3 and 1.5 nM at MCH1 and MCH2 receptors respectively. It can increase food intake in vivo. Alternative Names: Melanin concentrating hormone, human, mouse, rat; Asp-Phe-Asp-Met-Leu-Arg-Cys-Met-Leu-Gly-Arg-Val-Tyr-Arg-Pro-Cys-Trp-Gln-Val. Grades: ≥95% by HPLC. CAS No. 128315-56-0. Molecular formula: C105H160N30O26S4. Mole weight: 2386.84. | |
| MCL 0020 | MCL 0020 is a selective melanocortin MC4 receptor antagonist with IC50 value of 11.63nM at MC4 receptor. It shows anxiolytic-like activity in vivo. Alternative Names: MCL 0020; MCL0020; MCL-0020; N-Acetyl-3-(2-naphthalenyl)-D-alanyl-L-arginyl-3-(2-naphthalenyl)-L-alaninamide. Grades: >98%. CAS No. 475498-26-1. Molecular formula: C34H39N7O4. Mole weight: 609.73. | |
| MCT-ND6 | MCT-ND6 showed complete agonism compared with FPR1 agonist and FPR2 agonist. Grades: ≥95%. CAS No. 863418-59-1. Molecular formula: C38H54N6O9S2. Mole weight: 802.98. | |
| MDL 28170 | MDL 28170 is a calpain and cathepsin B inhibitor with Ki values of 10 and 25 nM respectively. It shows neuroprotective effects in vivo. MDL 28170 can attenuate depression in myocardial contractile performance which occurs during reperfusion following cardiac ischemia. Alternative Names: benzyl N-[(2S)-3-methyl-1-oxo-1-[(1-oxo-3-phenylpropan-2-yl)amino]butan-2-yl]carbamate. Grades: ≥ 95 % by HPLC. CAS No. 88191-84-8. Molecular formula: C22H26N2O4. Mole weight: 382.45. | |
| MDL 29913 | MDL 29913 is a selective NK2 tachykinin receptor antagonist which can be used in the treatment of IBS. Alternative Names: MDL 29913; MDL29913; MDL-29913; 1,4,7,10,13,16-Hexaazacyclooctadecane, Cyclic Peptide Deriv.; N-(2-Amino-4-methylpentyl)-N-methyl-L-leucyl-L-glutaminyl-L-tryptophyl-L-phenylalanylglycine (5→1)-Lactam. Grades: >97%. CAS No. 135721-56-1. Molecular formula: C40H56N8O6. Mole weight: 744.92. | |
| mDPR-Val-Cit-PAB-MMAE | mDPR-Val-Cit-PAB-MMAE consists the ADCs linker (mDPR-Val-Cit-PAB) and potent tubulin inhibitor (MMAE), mDPR-Val-Cit-PAB-MMAE is an antibody drug conjugate. Alternative Names: N-[(2S)-3-Amino-2-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)propanoyl]-L-valyl-N-{4-[(5S,8S,11S,12R)-11-[(2S)-2-butanyl]-12-(2-{(2S)-2-[(1R,2R)-3-{[(1S,2R)-1-hydroxy-1-phenyl-2-propanyl]amino}-1-methoxy-2 ;-methyl-3-oxopropyl]-1-pyrrolidinyl}-2-oxoethyl)-5,8-diisopropyl-4,10-dimethyl-3,6,9-trioxo-2,13-dioxa-4,7,10-triazatetradec-1-yl]phenyl}-N5-carbamoyl-L-ornithinamide; L-Ornithinamide, N-[(2S)-3-amino-2-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-1-oxopropyl]-L-valyl-N5-(aminocarbonyl)-N-[4-[(5S,8S,11S,12R)-12-[2-[(2S)-2-[(1R,2R)-3-[[(1R,2S)-2-hydroxy-1-methyl-2-phenyl ethyl]amino]-1-methoxy-2-methyl-3-oxopropyl]-1-pyrrolidinyl]-2-oxoethyl]-4,10-dimethyl-5,8-bis(1-methylethyl)-11-[(1S)-1-methylpropyl]-3,6,9-trioxo-2,13-dioxa-4,7,10-triazatetradec-1-yl]phenyl]-. Grades: ≥95%. CAS No. 1491152-26-1. Molecular formula: C65H100N12O15. Mole weight: 1289.561. | |
| MDVFMKGLSKAKEGV | MDVFMKGLSKAKEGV is a linear peptide epitope that has been studied as part of Alpha-synuclein from Homo sapiens (human) and Alpha-synuclein from Homo sapiens (human). | |
| Me-Ala-ol HCl | Me-Ala-ol HCl. Alternative Names: Me Ala ol HCl; (S)-2-(methylamino)propan-1-ol hydrochloride; (S)-2-(Methylamino)propan-1-ol HCl. CAS No. 40916-61-8. Molecular formula: C4H12ClNO. Mole weight: 125.6. | |
| Me-DL-Glu-OH | Me-DL-Glu-OH. Alternative Names: N-Methyl-DL-glutamic acid; 2-(methylamino)pentanedioic acid; H-DL-Meglu-OH; N-Methyl-DL-Glu; Me DL Glu OH. Grades: >99.0%(T). CAS No. 35989-16-3. Molecular formula: C6H11NO4. Mole weight: 161.16. | |
| Medusin-PD | Medusin-PD is a new antimicrobial peptide from the skin secretions of phyllomedusine frogs. Medusin-PD possessed inhibitory activity against the Gram-positive bacterium, Staphylococcus aureus and yeast, Candida albicans. Little haemolytic activity was demonstrable at peptide concentrations up to and including their respective MICs. | |
| Medusin-PH | Medusin-PH was found in Agalychnis callidryas and is active against S. aureus (MIC 32 mg/L) and C. albicans (MIC 128 mg/L). | |
| MEK1 Derived Peptide Inhibitor 1 | It is a peptide composed of the first 13 amino acids of the human mitogen-activated protein kinase kinase-1 (MEK1). It inhibits the in vitro activation of ERK2 by MEK1. Alternative Names: H-Met-Pro-Lys-Lys-Lys-Pro-Thr-Pro-Ile-Gln-Leu-Asn-Pro-OH; L-methionyl-L-prolyl-L-lysyl-L-lysyl-L-lysyl-L-prolyl-L-threonyl-L-prolyl-L-isoleucyl-L-glutaminyl-L-leucyl-L-asparagyl-L-proline. Grades: >98%. Molecular formula: C68H118N18O17S. Mole weight: 1491.84. | |
| Melanin Concentrating Hormone, salmon | Melanin Concentrating Hormone (MCH), salmon is a 19-amino acid neuropeptide, originally found in the pituitary gland of teleost fish, that regulates food intake, energy balance, sleep status and the cardiovascular system. MCH is a ligand for orphan G protein coupled receptor (SLC-1/GPR24) and MCHR2. Alternative Names: MCH (salmon); Asp-Thr-Met-Arg-Cys-Met-Val-Gly-Arg-Val-Tyr-Arg-Pro-Cys-Trp-Glu-Val (Disulfide bridge: Cys5-Cys14); L-alpha-aspartyl-L-threonyl-L-methionyl-L-arginyl-L-cysteinyl-L-methionyl-L-valyl-glycyl-L-arginyl-L-valyl-L-tyrosyl-L-arginyl-L-prolyl-L-cysteinyl-L-tryptophyl-L-alpha-glutamyl-L-valine (5->14)-disulfide. Grades: ≥90%. CAS No. 87218-84-6. Molecular formula: C89H139N27O24S4. Mole weight: 2099.48. | |
| Melanin Concentrating Hormone, salmon acetate | Melanin Concentrating Hormone, salmon acetate is a 19-amino acid neuropeptide, originally found in the pituitary gland of teleost fish, that regulates food intake, energy balance, sleep status and the cardiovascular system. MCH is a ligand for orphan G protein-coupled receptor (SLC-1/GPR24) and MCHR2. Alternative Names: MCH (salmon) acetate; L-Valine, L-α-aspartyl-L-threonyl-L-methionyl-L-arginyl-L-cysteinyl-L-methionyl-L-valylglycyl-L-arginyl-L-valyl-L-tyrosyl-L-arginyl-L-prolyl-L-cysteinyl-L-tryptophyl-L-α-glutamyl-, cyclic (5→14)-disulfide acetate; Melanin-concentrating hormone (Oncorhynchus keta) acetate; Melanin-concentrating hormone (Carassius auratus) acetate; Melanin-concentrating hormone (Oncorhynchus keta reduced), cyclic (5→14)-disulfide acetate; Salmon melanin-concentrating hormone acetate; H-Asp-Thr-Met-Arg-Cys-Met-Val-Gly-Arg-Val-Tyr-Arg-Pro-Cys-Trp-Glu-Val-OH.CH3CO2H (Disulfide bridge: Cys5-Cys14); L-alpha-aspartyl-L-threonyl-L-methionyl-L-arginyl-L-cysteinyl-L-methionyl-L-valyl-glycyl-L-arginyl-L-valyl-L-tyrosyl-L-arginyl-L-prolyl-L-cysteinyl-L-tryptophyl-L-alpha-glutamyl-L-valine (5->14)-disulfide. Grades: ≥95%. Molecular formula: C91H143N27O26S4. Mole weight: 2159.55. | |
| Melanocyte Protein PMEL 17 (185-193) (human, bovine, mouse) | Melanocyte Protein PMEL 17 (185-193) (human, bovine, mouse) is a peptide derived from Melanocyte Protein PMEL 17, a 100 kDa type I transmembrane glycoprotein that is expressed primarily in pigment cells of the skin and eye. Alternative Names: H-Ile-Thr-Asp-Gln-Val-Pro-Phe-Ser-Val-OH; gp100 (209-217). CAS No. 162558-10-3. Molecular formula: C46H72N10O15. Mole weight: 1005.12. | |
| Melanocyte protein Pmel 17 precursor (40-57) | A fragment of Melanocyte protein Pmel 17 precursor which plays a central role in the biogenesis of melanosomes. It is beneficial to research in the treatment of melanoma. | |
| Melanocyte protein Pmel 17 precursor (44-57) | A fragment of Melanocyte protein Pmel 17 precursor which plays a central role in the biogenesis of melanosomes. It is beneficial to research in the treatment of melanoma. | |
| Melanocyte protein Pmel 17 precursor (44-59) | A fragment of Melanocyte protein Pmel 17 precursor which plays a central role in the biogenesis of melanosomes. It is beneficial to research on the treatment of melanoma. Alternative Names: Trp-Asn-Arg-Gln-Leu-Tyr-Pro-Glu-Trp-Thr-Glu-Ala-Gln-Arg-Leu-Asp. CAS No. 195523-86-5. Molecular formula: C95H137N27O28. Mole weight: 2105.27. | |
| Melanocyte protein Pmel 17 precursor (45-57) | A fragment of Melanocyte protein Pmel 17 precursor which plays a central role in the biogenesis of melanosomes. It is beneficial to research in the treatment of melanoma. | |
| Melanocyte protein Pmel 17 precursor (46-57) | A fragment of Melanocyte protein Pmel 17 precursor which plays a central role in the biogenesis of melanosomes. It is beneficial to research in the treatment of melanoma. Alternative Names: ME20-M (46-57). Grades: 0.97. | |
| Melanoma antigen gp100 (280-288) | A peptide fragment of Melanoma antigen gp100. Gp100, also termed Pmel17 for premelanosomal protein, is a membrane-bound protein that is expressed in melanocytes and pigmented cells in the retina and in most malignant melanomas. | |
| Melanoma antigen preferentially expressed in tumors (100-108) | Melanoma antigen preferentially expressed in tumors (100-108) is a bioactive peptide of Melanoma antigen preferentially expressed in tumors. Melanoma antigen preferentially expressed in tumors inhibits the signaling of retinoic acid through the retinoic acid receptors RARA, RARB and RARG as a transcriptional repressor. Alternative Names: Opa-interacting protein 4 (100-108); Preferentially expressed antigen of melanoma (100-108). | |
| Melanoma antigen preferentially expressed in tumors (142-151) | Melanoma antigen preferentially expressed in tumors (142-151) is a bioactive peptide of Melanoma antigen preferentially expressed in tumors. Melanoma antigen preferentially expressed in tumors inhibits the signaling of retinoic acid through the retinoic acid receptors RARA, RARB and RARG as a transcriptional repressor. Alternative Names: Opa-interacting protein 4 (142-151); Preferentially expressed antigen of melanoma (142-151). | |
| Melanoma antigen preferentially expressed in tumors (300-309) | Melanoma antigen preferentially expressed in tumors (300-309) is a bioactive peptide of Melanoma antigen preferentially expressed in tumors. Melanoma antigen preferentially expressed in tumors inhibits the signaling of retinoic acid through the retinoic acid receptors RARA, RARB and RARG as a transcriptional repressor. Alternative Names: Opa-interacting protein 4 (300-309); Preferentially expressed antigen of melanoma (300-309). | |
| Melanoma antigen preferentially expressed in tumors (301-309) | Melanoma antigen preferentially expressed in tumors (301-309) is a bioactive peptide of Melanoma antigen preferentially expressed in tumors. Melanoma antigen preferentially expressed in tumors inhibits the signaling of retinoic acid through the retinoic acid receptors RARA, RARB and RARG as a transcriptional repressor. Alternative Names: Opa-interacting protein 4 (301-309); Preferentially expressed antigen of melanoma (301-309). | |
| Melanoma antigen preferentially expressed in tumors (425-433) | Melanoma antigen preferentially expressed in tumors (425-433) is a bioactive peptide of Melanoma antigen preferentially expressed in tumors. Melanoma antigen preferentially expressed in tumors inhibits the signaling of retinoic acid through the retinoic acid receptors RARA, RARB and RARG as a transcriptional repressor. Alternative Names: Opa-interacting protein 4 (425-433); Preferentially expressed antigen of melanoma (425-433). | |
| Melanoma-associated antigen C1 (1083-1091) | Melanoma-associated antigen C1 (1083-1091) is a peptide derived from Melanoma-associated antigen C1. Melanoma-associated antigen C1 is tumor-specific antigen that can be recognized by autologous cytolytic T lymphocytes. This protein contains a large number of unique short repetitive sequences in front of the MAGE-homologous sequence, and therefore is about 800 aa longer than the other MAGE proteins. Alternative Names: Cancer / testis antigen 7.1 (1083-1091); MAGE-C1 antigen (1083-1091). | |
Our database is helping our users find suppliers everyday.
